VF's Thriving E-commerce Strategy: A Game-Changer for the Outdoor Apparel Industry

VFS Options Frenzy: What You Need to Know

A surge in options trading activity has been observed in recent days for Vivos Therapeutics (VFS), a clinical-stage biotech company focused on developing treatments for chronic pain and other conditions. The frenzy has been driven by a combination of factors, including the company's recent announcement of positive Phase 2 trial results and the increasing popularity of options trading among individual investors.

According to data from Benzinga Pro, options trading volume for VFS has increased by over 300% in the past week alone, with the majority of the activity centered around the May 20th expiration date. This surge in trading activity has led to a significant increase in open interest, with the number of outstanding options contracts now exceeding 100,000.

The majority of the options activity is centered around the VFS May 20th $5 call option, with over 50,000 contracts traded in the past week. This option has seen a significant increase in trading activity, with the majority of the trades being buys. The $5 call option has also seen a significant increase in open interest, with over 20,000 contracts now outstanding.

The increasing popularity of options trading among individual investors has been driven by a combination of factors, including the increasing availability of options trading platforms and the growing awareness of the benefits of options trading. Options trading allows investors to gain exposure to a particular stock or market without having to purchase the underlying asset, which can be particularly attractive to investors who are looking to limit their exposure to market volatility.

In addition to the increasing popularity of options trading among individual investors, the surge in VFS options activity has also been driven by institutional investors. According to data from Benzinga Pro, institutional investors have been actively buying VFS options, with the majority of the trades being long calls.

The increasing popularity of VFS options trading has also led to a significant increase in trading volume for the company's stock. According to data from Benzinga Pro, VFS stock has seen a significant increase in trading volume, with the majority of the trades being buys. The stock has also seen a significant increase in open interest, with over 1 million shares now outstanding.

Overall, the surge in VFS options trading activity is a sign of increasing interest in the company's stock and its potential for future growth. As the company continues to make progress on its clinical trials and other initiatives, it is likely that options trading activity will remain strong in the coming weeks and months.